ReNeuron Group (AgeTech UK) Biomed
Stroke oriented, stem cell therapies. Primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Investor Type:
N/A
Technology:
AgeTech Companies
Investment Stage:
N/A
Founded Date:
N/A
Industry:
UK AgeTech 2020
Employee Number:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Headquarters:
United Kingdom